MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

30 May 2023 Evaluate
The sales slipped to Rs. 1584.44 millions for the March 2023 quarter as against Rs. 1757.14 millions during the year-ago period.The company suffered a huge decline of -79.44% to Rs. 35.92  millions from Rs. 174.73 millions  of corresponding previous quarter.Operating profit for the quarter ended March 2023 decreased to 197.84 millions as compared to 256.55 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1584.44 1757.14 -9.83 6732.92 6798.89 -0.97 6732.92 6798.89 -0.97
Other Income 7.24 4.48 61.61 15.98 14.44 10.66 15.98 14.44 10.66
PBIDT 197.84 256.55 -22.88 1084.44 1199.45 -9.59 1084.44 1199.45 -9.59
Interest 73.60 44.86 64.07 228.72 126.24 81.18 228.72 126.24 81.18
PBDT 124.24 211.69 -41.31 855.72 1073.21 -20.27 855.72 1073.21 -20.27
Depreciation 74.22 42.39 75.09 273.55 176.36 55.11 273.55 176.36 55.11
PBT 50.02 169.30 -70.45 582.17 896.85 -35.09 582.17 896.85 -35.09
TAX 14.10 -5.43 -359.67 151.92 182.98 -16.97 151.92 182.98 -16.97
Deferred Tax -8.78 -7.85 11.85 -11.66 -6.14 89.90 -11.66 -6.14 89.90
PAT 35.92 174.73 -79.44 430.25 713.87 -39.73 430.25 713.87 -39.73
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 12.49 14.60 -14.48 16.11 17.64 -8.70 16.11 17.64 -8.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..